Published in Medical Letter on the CDC and FDA, September 18th, 2005
"The objective of this study was to identify antimicrobial resistance and class 1 integrons among Shiga toxin-producing Escherichia coli (STEC). Two-hundred and seventy-four STEC recovered from poultry, cattle, swine, and humans were characterized by antimicrobial susceptibility testing, screened for the presence of class 1 integrons by PCR, and assayed for integron transfer by conjugation," scientists writing in the Journal of Antimicrobial Chemotherapy report.
"Ninety-three...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.